Tumour suppressor TRIM33 targets nuclear β-catenin degradation
2015 · Nature Communications · 154 citations
https://doi.org/10.1038/ncomms7156
J
Jianfei Xue
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
2.1K
Citations
15
h-index
17
i10-index
Jianfei Xue is an academic researcher from Shijiazhuang Yiling Pharmaceutical (China). The author has contributed to research in topics: FOXO transcription factor regulation & Lymphoma Diagnosis and Treatment & Epigenetics and DNA Methylation. The author has an h-index of 15, co-authored 23 publications.
Papers by this author
worksmiR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis
2016 · Cancer Research · 93 citations
https://doi.org/10.1158/0008-5472.can-15-3073
Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression
2015 · Journal of Biological Chemistry · 33 citations
https://doi.org/10.1074/jbc.m115.662882
Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b study
2025 · Oral Oncology · 4 citations
https://doi.org/10.1016/j.oraloncology.2025.107211
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat